ALEXANDRA LEVY: Open Payments
NPI 1528439445 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 9 payments from 7 companies in 2025. Trend: 2023 $302 · 2024 $273 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $48 |
| Kestra Medical Technology Services, Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| ABBVIE INC. | 1 | $27 |
| Chiesi USA, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: ELIQUIS, Assure WCD, ZERBAXA, DALVANCE, MYCAPSSA, XIFAXAN, Veklury.
Industry payments across MD — which companies pay providers there.
